Dr. Shadma Shahin

Molecular Hemato-Oncologist

A conscientious Molecular Hemato-Oncologist with a heart for service and an eye for details

sapient.shahin@gmail.com

Book Appointment Learn More

Dr. Shadma Shahin - Consultant Molecular Hemato-Oncologist

About Dr. Shadma Shahin

Dr. Shadma Shahin - Consultant Hemato Pathologist

Dr. Shadma Shahin is a dedicated and experienced pathologist with extensive training in molecular hematology and oncology. With her fellowship from ACTREC, Tata Memorial Hospital, and years of clinical experience, she brings expertise in diagnostic pathology, laboratory management, and patient care.

Specializations

Molecular Hemato-oncology

Laboratory Quality Management

Advanced Hematology

Clinical Pathology

Educational Qualifications

Fellow Molecular Hemato-oncology

ACTREC, Tata Memorial Hospital

MD

J.N. Medical College - 2020

Post Doctoral Certificate Course - Advanced Hematology

Neuberg Anand Academy of Laboratory Medicine, Bengaluru - 2021

Basic Course in Biomedical Research (87%)

NPTEL, Cycle 5 - 2022

Training in Laboratory Quality Management System & Internal Audit

Institute of Applied Quality Management, Kolkata

Professional Experience

Senior Resident

MS Ramaiah Medical College, Bengaluru

March 2022 - March 2023

Consultant Hemato Pathologist

Bioline Laboratory, Kormangala

March 2021 - May 2021

Junior Resident (JR)

J.N. Medical College & Hospital, Aligarh

June 2017 - June 2020 (3 years)

Senior House Officer/Duty Doctor

Narayana Health Whitefield, Bengaluru

May 2016 - August 2016

Research & Publications

Published Research

Role of Direct Immunofluorescence in the diagnosis of Immune mediated Dermatological conditions

IJSR March 2023;12(3)

Prevalence of Hepatitis B&C infections in prospective blood donors deferred due to a history of Jaundice

IJMR Dec 2022;156(6)

A rare case of Conradi-Hunermann-Happle syndrome

Our Dermatology Online 2020;1

Research Work Presented

Current Molecular Diagnostics Practices in Clinical Oncology by International Academy of Pathology- Indian Division 2023, Mumbai: Presented poster "Just Another Kinase or JAK of all trades": JAK2 in Hematologic Oncology
HEMATCON 2023, Bhuvaneshwar: Presented paper "Clinico-pathological significance of JAK2 mutations in Acute Myeloid Leukemia"
Molecular Pathology Association of India annual Conference (MPAICON) 2024, AIIMS New Delhi: Presented poster "Myeloid neoplasm with ETV6::ABL1 fusion- Clinical, Laboratory and Genomic correlates"
American Society of Hematology (ASH) Annual Meeting and Exposition, December 2024 in San Diego California, USA: Presented poster "Double Trouble: Composite mutations in driver genes in Acute Myeloid Leukemia"

Book an Appointment

Schedule Your Online Consultation

Book an appointment for professional hemato pathology & oncology consultation. Dr. Shadma's team will contact you for confirmation.

* Appointments are subject to availability and confirmation

sapient.shahin@gmail.com

Monday - Friday: 9:00 AM (IST) - 5:00 PM (IST)

Saturday: 9:00 AM (IST) - 1:00 PM (IST)

Full Name *

Email Address *

WhatsApp Number * (with country code, e.g., +91xxxxxxxxxx)

Preferred Date *

Preferred Time *

Consultation Type *

Symptoms/Reason for Visit

Relevant Medical History

Frequently Asked Questions

What conditions does Dr. Shadma Shahin treat?

She focuses on molecular hemato-oncology, clinical pathology, and hematology-related conditions, including diagnostic review and second opinions.

Do you offer online consultations?

Yes. Consultations are conducted online, and the team will confirm availability after you submit the appointment request.

Can I request a second opinion on pathology reports?

Yes. You can request a second opinion for pathology reports and molecular diagnostic findings.

What information should I provide before the consultation?

Please share your recent reports, relevant medical history, and the reason for consultation for an effective review.

How do I book an appointment?

Fill out the appointment form on this page with your preferred date and time. The team will reach out to confirm.